Log In
Print
BCIQ
Print
Print this Print this
 

Milatuzumab (IMMU-115)

Also known as: hCD74

  Manage Alerts
Collapse Summary General Information
Company Immunomedics Inc.
DescriptionHumanized anti-CD74 mAb
Molecular Target CD74 molecule major histocompatibility complex class II invariant chain
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today